• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493941816250
Medical Device Problem Codes Failure to Advance (2524); Material Deformation (2976)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/26/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the procedure was aborted.The patient presented with coronary artery disease and underwent percutaneous coronary intervention.Following pre-dilatation with a wolverine cutting balloon, a 2.50 x 16mm synergy xd drug-eluting stent was advanced for treatment but failed to cross the lesion.During removal, the stent struts were damaged and the procedure was not completed due to unspecified reason.No patient complications were reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: synergy xd mr us 2.50 x 16mm stent delivery system catheter was returned for analysis.Examination of the crimped stent via scope found evidence of damage with proximal stent struts lifted.The undamaged crimped stent outer diameter was measured, and the result was within max crimped stent profile measurement.The balloon cones were reviewed via scope, and no issues were noted.The balloon wings were tightly wrapped and evenly folded.The balloon had not been subjected to positive pressure.A visual and microscopic examination of the bumper tip no issues.A visual and tactile examination of the hypotube found no issues.A visual and tactile examination of the outer and mid-shaft section and a visual examination of the inner lumen found no issues.No other issues were identified during the product analysis.
 
Event or Problem Description
It was reported that the procedure was aborted.The patient presented with coronary artery disease and underwent percutaneous coronary intervention.Following pre-dilatation with a wolverine cutting balloon, a 2.50 x 16mm synergy xd drug-eluting stent was advanced for treatment but failed to cross the lesion.During removal, the stent struts were damaged, and the procedure was not completed due to unspecified reason.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key16392269
Report Number2124215-2023-05366
Device Sequence Number12033831
Product Code NIQ
UDI-Device Identifier08714729980803
UDI-Public08714729980803
Combination Product (Y/N)Y
Initial Reporter CountryIN
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/22/2024
Device Model NumberH7493941816250
Device Lot Number0029148706
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/16/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/27/2023
Supplement Date Received by Manufacturer03/16/2023
Initial Report FDA Received Date02/16/2023
Supplement Report FDA Received Date03/23/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/23/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-